Northern Trust Named Best Private Bank in U.S.
Also Received Top Honors for Best Private Bank in North America for Entrepreneurs and Alternatives CHICAGO–(BUSINESS WIRE)–Northern Trust, a leading... Read more.
Gossamer Bio to Participate in Upcoming Investor Conferences
SAN DIEGO–(BUSINESS WIRE)–$GOSS—Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development... Read more.
Mogo Reports Continued Platform Growth and Record Assets Under Management in Q3 2025
Assets Under Management Reach Record $498 Million; Bitcoin Holdings Increase Over 300% Quarter-over-Quarter Wealth Revenue Up 27% Year-over-Year; Payments Revenue1... Read more.
DoubleVerify Reports Third Quarter 2025 Financial Results
Delivered 11% Year-over-Year Revenue Growth to $188.6 Million and 35% Adjusted EBITDA Margins reaching $65.9 Million Raised Full-Year 2025 Adjusted EBITDA margin... Read more.
Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie
Net proceeds will be applied to debt reduction, advancing Organon’s ongoing deleveraging efforts Positions Organon for future investment in growth opportunities... Read more.
ADNOC Partners With Comera Financial Holdings to Empower Its UAE Suppliers and SMEs With Smart Financing Solutions
Strategic partnership unlocks quick access to purchase order financing through an automated platform Initiative to enhance SME cash flow, strengthen supply chain... Read more.
Novanta Inc. Announces Pricing of $550,000,000 Tangible Equity Units Offering
BOSTON–(BUSINESS WIRE)–Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced... Read more.
Ubiquiti Inc. Reports First Quarter Fiscal 2026 Financial Results
~ Revenues of $733.8 million ~ ~ GAAP Diluted Earnings Per Share of $3.43 ~ NEW YORK–(BUSINESS WIRE)–Ubiquiti Inc. (NYSE: UI) (“Ubiquiti”... Read more.
Fulgent Reports Third Quarter 2025 Financial Results
Revenue of $84.1 million, growing 17% year-over-year Raising Full Year 2025 Revenue Guidance to $325.0 million Raising Full Year 2025 EPS Guidance to GAAP loss of... Read more.
Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule... Read more.